Santi Nolasco Raffaele Campisi Rossella Intravaia Morena Porto Corrado Pelaia Nunzio Crimi Claudia Crimi
10.12688/f1000research.24603.2
F1000Res
2020 Jun 23;9:637.
anti-il-5 antibody asthma control test asthma exacerbation benralizumab eosinophilic asthma severe refractory asthma speed of onset
CC BY
https://pubmed.ncbi.nlm.nih.gov/32864107/
Anti-Asthmatic Agents / therapeutic use Antibodies, Monoclonal, Humanized / therapeutic use Asthma / drug therapy
Anti-Asthmatic Agents / therapeutic use Antibodies, Monoclonal, Humanized / therapeutic use Asthma / drug therapy Case Reports Adrenal Cortex Hormones Disease Progression Female Humans Middle Aged Adrenal Cortex Hormones Anti-Asthmatic Agents Antibodies, Monoclonal, Humanized benralizumab
PMC7443779
32864107
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use
2020